Reify Health, a leading provider of solutions that empower the clinical trial ecosystem, announced a $220M Series D round co-led by Altimeter Capital and...
SK Chemicals said it would start joint research on innovative new drugs with Oncobix, a synthetic new drug developer.
Under the accord, Oncobix will derive...
BioNTech SE and Matinas BioPharma, a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid...
RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced study results in which opaganib, a leading oral drug candidate for hospitalized patients with moderate to...
Engitix Ltd., a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, April...
Pfizer Inc. and ReViral Ltd. announced today that the companies have entered into a definitive agreement under which Pfizer will acquire ReViral, a privately...